Table of Contents
Chapter 1 Overview of Intensive Anti-Aging Treatment
    1.1 Definition of Intensive Anti-Aging Treatment in This Report
    1.2 Commercial Types of Intensive Anti-Aging Treatment
        1.2.1 Anti-Wrinkle Cream
        1.2.2 Anti-stretch mark Cream
        1.2.3 UV absorber
    1.3 Downstream Application of Intensive Anti-Aging Treatment
        1.3.1 Retail Pharmacies
        1.3.2 Online Pharmacies
        1.3.3 Drug Store
    1.4 Development History of Intensive Anti-Aging Treatment
    1.5 Market Status and Trend of Intensive Anti-Aging Treatment 2013-2023
        1.5.1 Global Intensive Anti-Aging Treatment Market Status and Trend 2013-2023
        1.5.2 Regional Intensive Anti-Aging Treatment Market Status and Trend 2013-2023
Chapter 2 Global Market Status and Forecast by Regions
    2.1 Market Development of Intensive Anti-Aging Treatment 2013-2017
    2.2 Sales Market of Intensive Anti-Aging Treatment by Regions
        2.2.1 Sales Volume of Intensive Anti-Aging Treatment by Regions
        2.2.2 Sales Value of Intensive Anti-Aging Treatment by Regions
    2.3 Production Market of Intensive Anti-Aging Treatment by Regions
    2.4 Global Market Forecast of Intensive Anti-Aging Treatment 2018-2023
        2.4.1 Global Market Forecast of Intensive Anti-Aging Treatment 2018-2023
        2.4.2 Market Forecast of Intensive Anti-Aging Treatment by Regions 2018-2023
Chapter 3 Global Market Status and Forecast by Types
    3.1 Sales Volume of Intensive Anti-Aging Treatment by Types
    3.2 Sales Value of Intensive Anti-Aging Treatment by Types
    3.3 Market Forecast of Intensive Anti-Aging Treatment by Types
Chapter 4 Global Market Status and Forecast by Downstream Industry
    4.1 Global Sales Volume of Intensive Anti-Aging Treatment by Downstream Industry
    4.2 Global Market Forecast of Intensive Anti-Aging Treatment by Downstream Industry
Chapter 5 North America Market Status by Countries, Type, Manufacturers and Downstream Industry
    5.1 North America Intensive Anti-Aging Treatment Market Status by Countries
        5.1.1 North America Intensive Anti-Aging Treatment Sales by Countries (2013-2017)
        5.1.2 North America Intensive Anti-Aging Treatment Revenue by Countries (2013-2017)
        5.1.3 United States Intensive Anti-Aging Treatment Market Status (2013-2017)
        5.1.4 Canada Intensive Anti-Aging Treatment Market Status (2013-2017)
        5.1.5 Mexico Intensive Anti-Aging Treatment Market Status (2013-2017)
    5.2 North America Intensive Anti-Aging Treatment Market Status by Manufacturers
    5.3 North America Intensive Anti-Aging Treatment Market Status by Type (2013-2017)
        5.3.1 North America Intensive Anti-Aging Treatment Sales by Type (2013-2017)
        5.3.2 North America Intensive Anti-Aging Treatment Revenue by Type (2013-2017)
    5.4 North America Intensive Anti-Aging Treatment Market Status by Downstream Industry (2013-2017)
Chapter 6 Europe Market Status by Countries, Type, Manufacturers and Downstream Industry
    6.1 Europe Intensive Anti-Aging Treatment Market Status by Countries
        6.1.1 Europe Intensive Anti-Aging Treatment Sales by Countries (2013-2017)
        6.1.2 Europe Intensive Anti-Aging Treatment Revenue by Countries (2013-2017)
        6.1.3 Germany Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.4 UK Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.5 France Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.6 Italy Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.7 Russia Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.8 Spain Intensive Anti-Aging Treatment Market Status (2013-2017)
        6.1.9 Benelux Intensive Anti-Aging Treatment Market Status (2013-2017)
    6.2 Europe Intensive Anti-Aging Treatment Market Status by Manufacturers
    6.3 Europe Intensive Anti-Aging Treatment Market Status by Type (2013-2017)
        6.3.1 Europe Intensive Anti-Aging Treatment Sales by Type (2013-2017)
        6.3.2 Europe Intensive Anti-Aging Treatment Revenue by Type (2013-2017)
    6.4 Europe Intensive Anti-Aging Treatment Market Status by Downstream Industry (2013-2017)
Chapter 7 Asia Pacific Market Status by Countries, Type, Manufacturers and Downstream Industry
    7.1 Asia Pacific Intensive Anti-Aging Treatment Market Status by Countries
        7.1.1 Asia Pacific Intensive Anti-Aging Treatment Sales by Countries (2013-2017)
        7.1.2 Asia Pacific Intensive Anti-Aging Treatment Revenue by Countries (2013-2017)
        7.1.3 China Intensive Anti-Aging Treatment Market Status (2013-2017)
        7.1.4 Japan Intensive Anti-Aging Treatment Market Status (2013-2017)
        7.1.5 India Intensive Anti-Aging Treatment Market Status (2013-2017)
        7.1.6 Southeast Asia Intensive Anti-Aging Treatment Market Status (2013-2017)
        7.1.7 Australia Intensive Anti-Aging Treatment Market Status (2013-2017)
    7.2 Asia Pacific Intensive Anti-Aging Treatment Market Status by Manufacturers
    7.3 Asia Pacific Intensive Anti-Aging Treatment Market Status by Type (2013-2017)
        7.3.1 Asia Pacific Intensive Anti-Aging Treatment Sales by Type (2013-2017)
        7.3.2 Asia Pacific Intensive Anti-Aging Treatment Revenue by Type (2013-2017)
    7.4 Asia Pacific Intensive Anti-Aging Treatment Market Status by Downstream Industry (2013-2017)
Chapter 8 Latin America Market Status by Countries, Type, Manufacturers and Downstream Industry
    8.1 Latin America Intensive Anti-Aging Treatment Market Status by Countries
        8.1.1 Latin America Intensive Anti-Aging Treatment Sales by Countries (2013-2017)
        8.1.2 Latin America Intensive Anti-Aging Treatment Revenue by Countries (2013-2017)
        8.1.3 Brazil Intensive Anti-Aging Treatment Market Status (2013-2017)
        8.1.4 Argentina Intensive Anti-Aging Treatment Market Status (2013-2017)
        8.1.5 Colombia Intensive Anti-Aging Treatment Market Status (2013-2017)
    8.2 Latin America Intensive Anti-Aging Treatment Market Status by Manufacturers
    8.3 Latin America Intensive Anti-Aging Treatment Market Status by Type (2013-2017)
        8.3.1 Latin America Intensive Anti-Aging Treatment Sales by Type (2013-2017)
        8.3.2 Latin America Intensive Anti-Aging Treatment Revenue by Type (2013-2017)
    8.4 Latin America Intensive Anti-Aging Treatment Market Status by Downstream Industry (2013-2017)
Chapter 9 Middle East and Africa Market Status by Countries, Type, Manufacturers and Downstream Industry
    9.1 Middle East and Africa Intensive Anti-Aging Treatment Market Status by Countries
        9.1.1 Middle East and Africa Intensive Anti-Aging Treatment Sales by Countries (2013-2017)
        9.1.2 Middle East and Africa Intensive Anti-Aging Treatment Revenue by Countries (2013-2017)
        9.1.3 Middle East Intensive Anti-Aging Treatment Market Status (2013-2017)
        9.1.4 Africa Intensive Anti-Aging Treatment Market Status (2013-2017)
    9.2 Middle East and Africa Intensive Anti-Aging Treatment Market Status by Manufacturers
    9.3 Middle East and Africa Intensive Anti-Aging Treatment Market Status by Type (2013-2017)
        9.3.1 Middle East and Africa Intensive Anti-Aging Treatment Sales by Type (2013-2017)
        9.3.2 Middle East and Africa Intensive Anti-Aging Treatment Revenue by Type (2013-2017)
    9.4 Middle East and Africa Intensive Anti-Aging Treatment Market Status by Downstream Industry (2013-2017)
Chapter 10 Market Driving Factor Analysis of Intensive Anti-Aging Treatment
    10.1 Global Economy Situation and Trend Overview
    10.2 Intensive Anti-Aging Treatment Downstream Industry Situation and Trend Overview
Chapter 11 Intensive Anti-Aging Treatment Market Competition Status by Major Manufacturers
    11.1 Production Volume of Intensive Anti-Aging Treatment by Major Manufacturers
    11.2 Production Value of Intensive Anti-Aging Treatment by Major Manufacturers
    11.3 Basic Information of Intensive Anti-Aging Treatment by Major Manufacturers
        11.3.1 Headquarters Location and Established Time of Intensive Anti-Aging Treatment Major Manufacturer
        11.3.2 Employees and Revenue Level of Intensive Anti-Aging Treatment Major Manufacturer
    11.4 Market Competition News and Trend
        11.4.1 Merger, Consolidation or Acquisition News
        11.4.2 Investment or Disinvestment News
        11.4.3 New Product Development and Launch
Chapter 12 Intensive Anti-Aging Treatment Major Manufacturers Introduction and Market Data
    12.1 DRAN
        12.1.1 Company profile
        12.1.2 Representative Intensive Anti-Aging Treatment Product
        12.1.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of DRAN
    12.2 Allergan
        12.2.1 Company profile
        12.2.2 Representative Intensive Anti-Aging Treatment Product
        12.2.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Allergan
    12.3 Clarins
        12.3.1 Company profile
        12.3.2 Representative Intensive Anti-Aging Treatment Product
        12.3.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Clarins
    12.4 Coty
        12.4.1 Company profile
        12.4.2 Representative Intensive Anti-Aging Treatment Product
        12.4.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Coty
    12.5 L’Oreal
        12.5.1 Company profile
        12.5.2 Representative Intensive Anti-Aging Treatment Product
        12.5.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of L’Oreal
    12.6 Elemis
        12.6.1 Company profile
        12.6.2 Representative Intensive Anti-Aging Treatment Product
        12.6.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Elemis
    12.7 Garnier
        12.7.1 Company profile
        12.7.2 Representative Intensive Anti-Aging Treatment Product
        12.7.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Garnier
    12.8 Clinique Laboratories
        12.8.1 Company profile
        12.8.2 Representative Intensive Anti-Aging Treatment Product
        12.8.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Clinique Laboratories
    12.9 Vichy Laboratories
        12.9.1 Company profile
        12.9.2 Representative Intensive Anti-Aging Treatment Product
        12.9.3 Intensive Anti-Aging Treatment Sales, Revenue, Price and Gross Margin of Vichy Laboratories
Chapter 13 Upstream and Downstream Market Analysis of Intensive Anti-Aging Treatment
    13.1 Industry Chain of Intensive Anti-Aging Treatment
    13.2 Upstream Market and Representative Companies Analysis
    13.3 Downstream Market and Representative Companies Analysis
Chapter 14 Cost and Gross Margin Analysis of Intensive Anti-Aging Treatment
    14.1 Cost Structure Analysis of Intensive Anti-Aging Treatment
    14.2 Raw Materials Cost Analysis of Intensive Anti-Aging Treatment
    14.3 Labor Cost Analysis of Intensive Anti-Aging Treatment
    14.4 Manufacturing Expenses Analysis of Intensive Anti-Aging Treatment
Chapter 15 Report Conclusion
Chapter 16 Research Methodology and Reference
    16.1 Methodology/Research Approach
        16.1.1 Research Programs/Design
        16.1.2 Market Size Estimation
        16.1.3 Market Breakdown and Data Triangulation
    16.2 Data Source
        16.2.1 Secondary Sources
        16.2.2 Primary Sources
    16.3 Reference

Companies Included in Reports: